Altria Group, Inc. · NYSE:MO

Altria — Q2 2021 Earnings Presentation

30 slides from Altria's earnings presentation, Jul 29, 2021

  1. Slide 1: Altria's Second-Quarter 2021 Earnings Conference Call

    Altria’s Second-Quarter 2021 Earnings Conference Call July 29, 2021 1 | ALCS | Q2 2021 | 7.29.21 | For Investor Purposes ONLY

  2. Slide 2: Safe Harbor Statement

    Safe Harbor Statement Statements, including earnings guidance, in this presentation that are not reported financial results or other historical information are “forward-looking statements” within the meaning of Private Securities Litigation Reform Act of 1995. Such forward-looking statements are bas

  3. Slide 3: Moving Beyond Smoking

    Responsibly lead the transition Moving Beyond Smoking ™ of adult smokers to a smoke-free* future *Previous Vision language: Responsibly lead the transition of adult smokers to a non-combustible future 3 | ALCS | Q2 2021 | 7.29.21 | For Investor Purposes ONLY

  4. Slide 4: Q2 2021: Adjusted Diluted Earnings Per Share

    Q2 2021: Adjusted Diluted Earnings Per Share* Adjusted Diluted EPS +12.8% $1.23 $1.09 2020 2021 *For reconciliations of non-GAAP to GAAP measures visit altria.com. 4 | ALCS | Q2 2021 | 7.29.21 | For Investor Purposes ONLY

  5. Slide 5: Smokeable Products Segment

    Smokeable Products Segment Adjusted Operating Companies Income* (OCI) Adjusted OCI Adjusted OCI ($ in millions) ($ in millions) +11.0% +5.3% $5,159 $4,900 $2,784 $2,508 Q2 2020 Q2 2021 1H 2020 1H 2021 *For reconciliations of non-GAAP to GAAP measures visit altria.com. 5 | ALCS | Q2 2021 | 7.29.21 |

  6. Slide 6: Oral Tobacco Products Segment

    Oral Tobacco Products Segment Adjusted OCI* Adjusted OCI Adjusted OCI ($ in millions) ($ in millions) +3.5% +3.3% $901 $872 $456 $472 Q2 2020 Q2 2021 1H 2020 1H 2021 *For reconciliations of non-GAAP to GAAP measures visit altria.com. 6 | ALCS | Q2 2021 | 7.29.21 | For Investor Purposes ONLY

  7. Slide 7: Unconstrained on! Manufacturing Capacity

    Unconstrained on! Manufacturing Capacity  Helix achieved unconstrained manufacturing capacity for the current U.S. market  As the category grows, Helix plans to further increase on! capacity ahead of expected demand 7 | ALCS | Q2 2021 | 7.29.21 | For Investor Purposes ONLY

  8. Slide 8: on! Performance

    on! Performance Retail Store Count Share of Oral Tobacco Category (in thousands) (total U.S.) 105 93 2.0 78 1.7 60 1.1 40 26 15 Q4 '19 Q1' 20 Q2 '20 Q3 '20 Q4 '20 Q1' 21 Q2 '21 Q4' 20 Q1 '21 Q2 '21 Source: STARS week ending 07/04/2021 Source: IRI InfoScan Oral Tobacco MOC, week ending 07/04/2021 8 |

  9. Slide 9: Building on! Brand Awareness and Trial

    Building on! Brand Awareness and Trial Adult Smoker Adult Dipper 9 | ALCS | Q2 2021 | 7.29.21 | For Investor Purposes ONLY

  10. Slide 10: IQOS Expansion Performance

    IQOS Expansion Performance GA, VA, NC & SC IQOS Device Sales GA, VA, NC, SC + All Metro Areas Flexible Retail + Boutiques Convenience 45% 55% HeatSticks only Devices & HeatSticks Q4 2020 Q1 2021 Q2 2021 All-third party trademarks remain the property of their respective owners. Source: STARS data thr

  11. Slide 11: IQOS Expansion Performance

    IQOS Expansion Performance Northern Virginia Market IQOS Device Penetration % ATL CLT NoVA IQOS Boutique, Northern Virginia 0 2 4 6 8 10 12 14 16 18 20 22 24 26 Weeks All-third party trademarks remain the property of their respective owners. Source: POS Scan data through WE 7/3/21. CEA data through

  12. Slide 12: Strengthening Capabilities in Support of Our Vision

    Strengthening Capabilities in Support of Our Vision 12 | ALCS | Q2 2021 | 7.29.21 | For Investor Purposes ONLY

  13. Slide 13: Altria's Scientific Engagement

    Altria’s Scientific Engagement Dr. Maria Gogova, Altria Chief Scientific Officer 13 | ALCS | Q2 2021 | 7.29.21 | For Investor Purposes ONLY

  14. Slide 14: 2021 Adjusted Diluted EPS Guidance

    2021 Adjusted Diluted EPS* Guidance We’ve raised the lower end of our full-year 2021 adjusted diluted EPS guidance to be in the range of $4.56 to $4.62. This range represents a growth rate of 4.5% to 6% from a $4.36 base in 2020. This updated guidance reflects: • continued confidence in our tobacco

  15. Slide 15: Cigarette Trips and Volume Sales Trends

    Cigarette Trips and Volume Sales Trends1 2020, 2021 Total Trips Volume Per Trip (in millions) (in packs) 50 3 Millions - - 1/9 2/9 3/9 4/9 5/9 6/9 7/9 8/9 9/9 10/9 11/9 12/9 1/9 2/9 3/9 4/9 5/9 6/9 7/9 8/9 9/9 10/9 11/9 12/9 Source: Databricks POS Scan week ending 07.03.2021 as of 07.20.2021 1 Store

  16. Slide 16: Smokeable Products Segment: Adjusted OCI Margins

    Smokeable Products Segment Adjusted OCI Margins* Adjusted OCI Margins Adjusted OCI Margins +0.6pp +1.5pp 57.8% 58.4% 58.0% 56.5% Q2 2020 Q2 2021 1H 2020 1H 2021 *For reconciliations of non-GAAP to GAAP measures visit altria.com. 16 | ALCS | Q2 2021 | 7.29.21 | For Investor Purposes ONLY

  17. Slide 17: Adjusted Cigarette Decline Rates

    Adjusted Cigarette Decline Rates Smokeable Segment Total Industry Q1 '20 Q2 '20 Q3 '20 Q4 '20 Q1 '21 Q2 '21 Q1 '20 Q2 '20 Q3 '20 Q4 '20 Q1 '21 Q2 '21 1.0 % 0.5 % 0% (1.0)% (1.0)% (2.0)% (2.0)% (2.0)% (3.5)% (3.5)% (4.5)% (5.0)% 1H 2021 = 1H 2021 = (4.0)% (4.0)% Source: AVI SCMI estimates – rounded t

  18. Slide 18: Smokeable Products Segment: Marlboro Retail Share

    Smokeable Products Segment Marlboro Retail Share 43.2 43.1 43.1 43.2 42.7 ∆ vs. (0.5) +0.1 +0.2 +0.4 +0.5 YAGO Q2 '20 Q3 '20 Q4 '20 Q1 '21 Q2 '21 Source: IRI/MSAi InfoScan Cigarette 2021 – Blended, week ending 07/04/21 18 | ALCS | Q2 2021 | 7.29.21 | For Investor Purposes ONLY

  19. Slide 19: Discount Segment Retail Share

    Discount Segment Retail Share Total Discount Segment (%) Deep Discount Branded Discount 30.0 25.2 24.9 24.7 25.0 25.3 25.0 15.3 15.0 14.9 14.8 14.9 14.7 9.9 9.9 9.8 10.2 10.4 10.3 0.0 Q1 '20 Q2 '20 Q3 '20 Q4 '20 Q1 '21 Q2' 21 Source: IRI/MSAi InfoScan Cigarette 2021 – Blended, week ending 07/04/21 1

  20. Slide 20: John Middleton Cigars

    John Middleton Cigars 20 | ALCS | Q2 2021 | 7.29.21 | For Investor Purposes ONLY

  21. Slide 21: Oral Tobacco Products Segment: Adjusted OCI Margins

    Oral Tobacco Products Segment Adjusted OCI Margins* Adjusted OCI Margins Adjusted OCI Margins (1.1pp) (1.0pp) 72.8% 71.7% 72.9% 71.9% Q2 2020 Q2 2021 1H 2020 1H 2021 *For reconciliations of non-GAAP to GAAP measures visit altria.com. 21 | ALCS | Q2 2021 | 7.29.21 | For Investor Purposes ONLY

  22. Slide 22: Oral Tobacco Products Segment Retail Share

    Oral Tobacco Products Segment Retail Share (2.2pp) 50.0 47.8 Q2 2020 Q2 2021 Source: IRI/MSAi InfoScan Oral Tobacco 2021 – MOC, week ending 07/04/21 22 | ALCS | Q2 2021 | 7.29.21 | For Investor Purposes ONLY

  23. Slide 23: E-Vapor Category Volume

    E-Vapor Category Volume Estimated Equivalized Volume (in billions of units) Quarterly Estimates Q2 2021 Category ∆ 0.7 2% Q/Q Increase 15% YOY Increase 0.50 0.50 0.51 0.49 0.45 0.46 0.46 0.44 0.44 0.40 0.0 Q1 '19 Q2 '19 Q3 '19 Q4 '19 Q1 '20 Q2 '20 Q3 '20 Q4 '20 Q1 '21 Q2 '21 Source: AVI SCMI estimat

  24. Slide 24: Our Alcohol Assets

    Our Alcohol Assets All-third party trademarks remain the property of their respective owners. 24 | ALCS | Q2 2021 | 7.29.21 | For Investor Purposes ONLY

  25. Slide 25: Ste. Michelle Wine Estates Transaction

    Ste. Michelle Wine Estates Transaction 25 | ALCS | Q2 2021 | 7.29.21 | For Investor Purposes ONLY

  26. Slide 26: Philip Morris Capital Corporation (PMCC)

    Philip Morris Capital Corporation (PMCC) Net Finance Assets ($ in millions) • We continue to make progress on ($59) our wind-down of PMCC $320 $261 • We expect to continue reducing this balance in 2021 through rent and asset sales and expect to fully complete the PMCC wind-down by the end of 2022 Q4

  27. Slide 27: Cronos Group Announces Strategic Investment in PharmaCann

    Cronos Group Announces Strategic Investment in PharmaCann, a Leading U.S. Cannabis Company All-third party trademarks remain the property of their respective owners. 27 | ALCS | Q2 2021 | 7.29.21 | For Investor Purposes ONLY

  28. Slide 28: Capital Allocation

    Capital Allocation  Repaid $1.5 billion of notes upon maturity Balance Sheet  Debt to EBITDA* was 2.3x as of the end of the second quarter  In the second quarter we paid $1.6 billion in dividends Dividends  We maintain our long-term objective of a dividend target payout ratio of approximately 80

  29. Slide 29: Corporate Responsibility Reports

    Corporate Responsibility Reports Available on www.altria.com 29 | ALCS | Q2 2021 | 7.29.21 | For Investor Purposes ONLY

  30. Slide 30: ALCS | Q2 2021 | 7.29.21 | For Investor Purposes ONLY

    ALCS | Q2 2021 | 7.29.21 | For Investor Purposes ONLY

Altria Group — Q2 2021 Earnings Presentation on 6ix